20
Dr. Reddy's Laboratories Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their significant offerings is Cetirizine dihydrochloride, Process II, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2009-206 - Rev 03
This Chemical Type CEP, issued on January 08, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1084 associated with this CEP further emphasizes